AlphaCentric Advisors’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$343K Sell
2024
Q2
$1.73M Hold
2024
Q1
$2.39M Hold
2023
Q4
$3.33M Buy
2023
Q3
$3.41M Hold
2023
Q2
$3.9M Buy
2023
Q1
$2.42M Buy
2022
Q4
$1.49M Buy
2022
Q3
$509K Buy
2021
Q4
Sell
2021
Q3
$562K Sell
2021
Q2
$712K Buy
2021
Q1
$161K Buy
2020
Q4
$28K Hold
2020
Q3
$29K Sell
2020
Q2
$36K Buy